Antioxidants for adults with chronic kidney disease-Reference-Cited by-同舟云学术

Antioxidants for adults with chronic kidney disease

Published:2023-11-02 Issue:11 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Colombijn Julia MT¹,Hooft Lotty²,Jun Min³,Webster Angela C⁴⁵⁶⁷,Bots Michiel L⁸,Verhaar Marianne C⁹,Vernooij Robin WM¹

Affiliation:

1. Department of Nephrology and Hypertension, Julius Center for Health Sciences and Primary Care; University Medical Center Utrecht; Utrecht Netherlands

2. Cochrane Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University; Utrecht Netherlands

3. The George Institute for Global Health, UNSW; Sydney Australia

4. Sydney School of Public Health, Faculty of Medicine and Health; The University of Sydney; Sydney Australia

5. Westmead Applied Research Centre; The University of Sydney at Westmead; Westmead Australia

6. NHMRC Clinical Trials Centre, Faculty of Medicine and Health; The University of Sydney; Sydney Australia

7. Department of Transplant and Renal Medicine; Westmead Hospital; Westmead Australia

8. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht; University of Utrecht; Utrecht Netherlands

9. Department of Nephrology and Hypertension; University of Utrecht; Utrecht Netherlands

Publisher

Wiley

Subject

Pharmacology (medical)

Reference464 articles.

1. An open, randomized, parallel group, multi-center study on the prognosis of hemodialysis patients with anemia treatment by combination therapy with iron and vitamin C and erythropoietin (ACTIVE study) [abstract no: FR-PO1559];Kuragano;Journal of the American Society of Nephrology,2011

2. Effect of protoconized therapy for renal anemia on adverse events of patients with maintenance hemodialysis;Kuragano;International Journal of Artificial Organs,2014

3. An open, randomized, parallel group, multi-center study on the prognosis of hemodialysis patients in anemia treatment by combination therapy with iron and vitamin C and erythropoietin (ACTIVE study) [abstract no: SAP516];Yahiro;Nephrology Dialysis Transplantation,2012

4. Effectiveness of N-acetylcysteine for preserving residual renal function in patients undergoing maintenance hemodialysis: multicenter randomized clinical trial;Ahmadi;Clinical & Experimental Nephrology,2017

5. Anti-inflammatory & anti-oxidative nutrition in hypoalbuminemic dialysis patients (AIONID) double-blind randomized placebo-controlled trial [abstract no: TH-OR090];Kalantar-Zadeh;Journal of the American Society of Nephrology,2011